Results 221 to 230 of about 2,683,923 (303)

Clinical feasibility of primary retrograde endovascular therapy via trans-ankle intervention: a retrospective single-center study. [PDF]

CVIR Endovasc
Miwa H, Hayakawa N, Tsurumaki T, Tsuchida Y, Inoue M, Ichihara S, Kushida S.   +6 more
europepmc   +1 more source

Atherosclerosis: From Pathogenesis to Therapeutic Interventions

MedComm, Volume 7, Issue 11, November 2026.
The diagram outlines the core mechanisms driving atherosclerosis, including endothelial dysfunction, inflammatory responses, phenotypic switching of smooth muscle cells, and the gut–vascular axis. It also presents the corresponding therapeutic approaches now under development, such as gene therapies, immunotherapies, and nanotechnology platforms ...
Enge Zhou, Chenxi Zhan, Yuting Li, Yi Zeng, Renfei Luo, Xin Ouyang, Shixing Liu, Renqiang Yang, Nianlong Yan, Long Jiang   +9 more
wiley   +1 more source

Effects of Danhong Injection on 90‐Day Functional Outcome in Acute Ischemic Stroke: An Adaptive, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase IV Trial

MedComm, Volume 7, Issue 11, November 2026.
In a randomized trial of 1505 thrombolysis‐ineligible AIS patients, 14‐day Danhong injection improved neurological recovery, raising mRS ≤1 rate by 5.33% versus placebo. RNA sequencing of 39 patients identified 19 DEMs, including the paired targeted modules HBG2/TMEM108, whose time‐dependent joint association with outcome (−0.729 to 1) was described ...
Jun Liu, Yilong Wang, Bingwei Chen, Jingjing Lu, Lin Chen, Shuang Guan, Yinli Shi, Wei Liu, Yanan Yu, Bing Li, Haixia Dang, Xiaolong Zhu, Fei Teng, Xuanzhu Liu, Niwen Zhou, Qiguang Chen, Chunti Shen, Lixing Zhu, Yongyan Wang, Xingquan Zhao, Zhong Wang, Danhong‐Stroke Trial Investigators   +21 more
wiley   +1 more source

Blood pressure variation and futile recanalisation in patients with large-vessel occlusion after endovascular therapy. [PDF]

BMJ Neurol Open
Cai T, Huang J, Yang S, Xie D, Guo Y, Yang J, Yang D, Hu J, Li F.   +8 more
europepmc   +1 more source

Geometry‐Related Technical Complications After LVAD Implantation: Impact on Device Dysfunction and Clinical Outcomes

Artificial Organs, Volume 50, Issue 11, Page 1605-1615, November 2026.
Preventable geometric failure modes, such as outflow graft kinking and inflow malposition, frequently cause HeartMate 3 dysfunction. This study identifies these complications as key drivers of device‐related morbidity, highlighting the importance of optimized surgical positioning to ensure long‐term device performance and improved clinical outcomes ...
Ali Saad Merzah, Ezin Deniz, Sara Knigge, Jasmin Hanke, Alina Zubarevich, Mohamad Dia, Chaikovska Sofia, Todurov Borys, Saeed Torabi, Bastian Schmack, Alexander Weymann, Zurab Darbaidze, Josephina Haunschild, Christian D. Etz, Max Biewer, Arjang Ruhparwar, Jan D. Schmitto, Günes Dogan   +17 more
wiley   +1 more source

Usefulness of ultrasonography to confirm hemostasis after femoral artery access in endovascular therapy. [PDF]

CVIR Endovasc
Shima Y, Bando R, Bando G, Irie N, Mushiake K, Tanaka H, Abe M.   +6 more
europepmc   +1 more source

SURGELLA: A Scoping Review of Impella‐Assisted Hemodynamic Support in High‐Risk Non‐Cardiac Surgery

Artificial Organs, Volume 50, Issue 11, Page 1532-1545, November 2026.
In selected patients with severe LV dysfunction, Impella‐supported non‐cardiac surgery may provide a temporary hemodynamic bridge to otherwise prohibitive procedures. Published evidence remains limited to a small number of highly selected cases, supporting technical feasibility rather than comparative benefit or generalizable safety.
Hussein Elghazaly, Mohammed Allaf, Areeb Mian, Hanad Ahmed, Alex Gordon‐Weeks, Alexander Tindale, Vasileios Panoulas   +6 more
wiley   +1 more source

Serum IL-6 and functional outcome after endovascular therapy: the mediating role of infarct volume growth in acute ischemic stroke. [PDF]

Front Immunol
Li S, Zhang S, Ji L, Qu Y, Huang Z, Gao J, Zhang Y, Li Z, Sun H, Zhu L, Jiang T, Yu Y, Deng Q.   +12 more
europepmc   +1 more source

Heart Donation After Controlled Circulatory Death in Noncardiac Surgery Hospitals With a Mobile Heart Team: A Case Series From an Italian Regional Program and Integrated Review of the Literature

Artificial Organs, Volume 50, Issue 11, Page 1657-1667, November 2026.
In this series of 19 DCD donors using TA‐NRP, 89.5% of hearts were successfully transplanted with no PGD, no postoperative ECMO, and no 30‐day mortality, demonstrating the feasibility and safety of this approach. ABSTRACT Controlled donation after circulatory death (cDCD) with thoracoabdominal normothermic regional perfusion (TA‐NRP) has emerged ...
Maria Benedetto, Valentina Roncarati, Arianna Campana, Erika Cordella, Domenico Nocera, Sofia Martin‐Suarez, Luca Botta, Davide Pacini, Letizia Perinati, Massimo Baiocchi, Tommaso Tonetti, Fabrizio Monaco   +11 more
wiley   +1 more source